Phosphatidylinositol 3-kinase-δ up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes.
about
Salidroside contributes to reducing blood pressure and alleviating cerebrovascular contractile activity in diabetic Goto-Kakizaki Rats by inhibition of L-type calcium channel in smooth muscle cellsExpression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway.DNA methylation mediates the impact of exposure to prenatal maternal stress on BMI and central adiposity in children at age 13½ years: Project Ice Storm.Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca²⁺ handling in smooth muscle cells.Functional characterization of voltage-dependent Ca(2+) channels in mouse pulmonary arterial smooth muscle cells: divergent effect of ROSMural propagation of descending vasa recta responses to mechanical stimulationInhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.Diabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle.Tuning in to the ‘right’ calcium channel regulation in experimental models of diabetes.Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter.Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta.Effects of streptozotocin and unilateral nephrectomy on L-type Ca²⁺ channels and membrane capacitance in arteriolar smooth muscle cells.Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.
P2860
Q33604575-66C9C751-34FB-43F6-A3E0-ED95D453D5DFQ35043317-D3AC46AF-377F-4091-9622-3DA326AE3B9AQ36214615-06F87EE1-4A95-4A37-B9A9-0CF410F95C67Q36790209-06DBCD17-8E72-4DB8-8963-A3F8A33047BBQ36914778-B5890912-4686-4F89-B4B8-AD1C8D116451Q37093686-41124F31-45C1-4433-8097-9EB23EB88C76Q38603120-89252E20-1C53-4790-93B6-8DD171F436DAQ39195631-0BE1C72E-51CE-4D0F-A8B8-1AD67665F009Q40960321-AABE908F-8B46-4BC5-AE7B-CFC5C2656CAFQ41484753-8A6A51CD-D7E9-4055-9ADB-01DED8543F18Q41789259-A8D4855C-7DE3-4967-AD81-D5052E9F5EEBQ42151307-E85A440D-2DF2-421A-99AC-104FB930D71CQ53261301-BFDEA202-8F63-4908-BE4B-7A170302E851Q54305936-A1BDCF15-3DC2-4901-9861-2599140726CC
P2860
Phosphatidylinositol 3-kinase-δ up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Phosphatidylinositol 3-kinase- ...... ouse model of type 1 diabetes.
@en
type
label
Phosphatidylinositol 3-kinase- ...... ouse model of type 1 diabetes.
@en
prefLabel
Phosphatidylinositol 3-kinase- ...... ouse model of type 1 diabetes.
@en
P2093
P2860
P1476
Phosphatidylinositol 3-kinase- ...... ouse model of type 1 diabetes.
@en
P2093
B A Rezende
L S A Capettini
M A A Medeiros
P P Campos
S F Cortes
S P Andrade
P2860
P304
P356
10.1111/J.1476-5381.2010.00955.X
P407
P577
2010-12-01T00:00:00Z